Vascular leakage in dengue hemorrhagic fever is associated with dengue infected monocytes, monocyte activation/exhaustion, and cytokines production

International Journal of Vascular Medicine

Volumn 2015, Issue , 2015, Pages

  Chunhakan, Sirichan ^a   Butthep, Punnee ^a   Yoksan, Sutee ^b   Tangnararatchakit, Kanchana ^a   Chuansumrit, Ampaiwan ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; EXHAUSTION; FEMALE; FLUORESCENCE; HEMATOCRIT; HUMAN; MALE; MONOCYTE; PRIORITY JOURNAL; VASCULAR DISEASE; VASCULAR LEAKAGE;

EID: 84924217312     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2015/917143     Document Type: Article

References (46)

1. B. E. E.Martina, P. Koraka, and A. D. M. E. Osterhaus, Dengue virus pathogenesis: an integrated view, Clinical Microbiology Reviews, vol. 22, no. 4, pp. 564-581, 2009.
2. A. B. Pérez, B. Sierra, G. Garcia et al., Tumor necrosis factoralpha, transforming growth factor-1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever, Human Immunology, vol. 71, no. 11, pp. 1135-1140, 2010.
3. K. Jessie, M. Y. Fong, S. Devi, S. K. Lam, and K. T. Wong, Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization, Journal of Infectious Diseases, vol. 189, no. 8, pp. 1411-1418, 2004.
4. A. P. Durbin, M. J. Vargas, K.Wanionek et al., Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever, Virology, vol. 376, no. 2, pp. 429-435, 2008.
5. I. Kurane and F. A. Ennis, Production of interferon alpha by dengue virus-infected human monocytes, Journal of General Virology, vol. 69, no. 2, pp. 445-449, 1988.
6. Z. Kou, M. Quinn, H. Chen et al., Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells, Journal of Medical Virology, vol. 80, no. 1, pp. 134-146, 2008.
7. I. Bosch, K. Xhaja, L. Estevez et al., Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge, Journal of Virology, vol. 76, no. 11, pp. 5588-5597, 2002.
8. Y.-C. Chen and S.-Y.Wang, Activation of terminally differentiated humanmonocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide, Journal of Virology, vol. 76, no. 19, pp. 9877-9887, 2002.
9. J. M. Carr, H. Hocking, K. Bunting et al., Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers, Journal of Medical Virology, vol. 69, no. 4, pp. 521-528, 2003.
10. S. B.Halstead, Pathogenisis of dengue: challenges tomolecular biology, Science, vol. 239, no. 4839, pp. 476-481, 1988.
11. S. B. Halstead, Dengue, The Lancet, vol. 370, no. 9599, pp. 1644-1652, 2007.
12. D. F.Mangan and S.M.Wahl, Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines, Journal of Immunology, vol. 147, no. 10, pp. 3408-3412, 1991.
13. D. F.Mngan, G. R.Welch, and S.M.Wahl, Lipopolysaccharide, tumor necrosis factor, and IL-1 prevent programmed cell death (apoptosis) in human peripheral blood monocytes, The Journal of Immunology, vol. 146, no. 5, pp. 1541-1546, 1991.
14. D. M. Mosser and X. Zhang, Interleukin-10: new perspectives on an old cytokine, Immunological Reviews, vol. 226, no. 1, pp. 205-218, 2008.
15. G. N. Malavige, L. Gomes, L. Alles et al., Serum IL-10 as a marker of severe dengue infection, BMC Infectious Diseases, vol. 13, no. 1, article 341, 2013.
16. T.-T. Tsai, Y.-J. Chuang, Y.-S. Lin, S.-W. Wan, C.-L. Chen, and C.-F. Lin, An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection, Journal of Biomedical Science, vol. 20, article 40, 2013.
17. K. I. Schexneider and E. A. Reedy, Thrombocytopenia in dengue fever,CurrentHematology Reports, vol. 4, no. 2,pp. 145-148, 2005.
18. S. Green,D.W. Vaughn, S. Kalayanarooj et al., Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity, Journal ofMedical Virology, vol. 59, no. 3, pp. 329-334, 1999.
19. E. L. Azeredo, S. M. O. Zagne, M. A. Santiago et al., Characterisation of lymphocyte response and cytokine patterns with dengue fever, Immunobiology, vol. 204, no.4,pp. 494-507, 2001.
20. D. H. Libraty, T. P. Endy, H.-S. H. Houng et al., Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections, Journal of Infectious Diseases, vol. 185, no. 9, pp. 1213-1221, 2002.
21. J. Mongkolsapaya, W. Dejnirattisai, X.-N. Xu et al., Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever, Nature Medicine, vol. 9, no. 7, pp. 921-927, 2003.
22. A. B. Pérez, G. García, B. Sierra et al., IL-10 levels in dengue patients: some findings from the exceptional epidemiological conditions in Cuba, Journal of Medical Virology, vol. 73, no. 2, pp. 230-234, 2004.
23. S. Chunhakan, P. Butthep, S. Yoksan, K. Tangnararatchakit, and A. Chuansumrit, Early diagnosis of dengue virus infection by detection of dengue viral antigen in peripheral blood mononuclear cell, Pediatric Infectious Disease Journal, vol. 28, no. 12, pp. 1085-1088, 2009.
24. P. Butthep, S. Chunhakan, S. Yoksan, K. Tangnararatchakit, and A. Chuansumrit, Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever, Pediatric Infectious Disease Journal, vol. 31, no. 12, pp. e232-e238, 2012.
25. World Health Organization, Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, World Health Organization, Geneva, Switzerland, 2nd edition, 1997.
26. L. Rosen and D. Gubler, The use of mosquitos to detect and propagate dengue viruses, The American Journal of Tropical Medicine and Hygiene, vol. 23, no. 6, pp. 1153-1160, 1974.
27. B. L. Innis, A. Nisalak, S. Nimmannitya et al., An enzymelinked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate,American Journal of TropicalMedicine andHygiene, vol. 40, no. 4, pp. 418- 427, 1989.
28. A. J. Johnson, D. A. Martin, N. Karabatsos, and J. T. Roehrig, Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay, Journal of ClinicalMicrobiology, vol. 38, no. 5, pp. 1827-1831, 2000.
29. P. Butthep, S. Rummavas, R.Wisedpanichkij, S. Jindadamrongwech, S. Fucharoen, and A. Bunyaratvej, Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia, American Journal of Hematology, vol. 70, no. 2, pp. 100-106, 2002.
30. M. M. Khin, N. Bhamarapravati, S. Yoksan, J. Rabablert, and P. Cipkokwai, Study of infection and biological attributes of the dengue 1 viruses recovered from human volunteers immunized with dengue 1 candidate vaccine after oral infection of Aedes aegypti,The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 21, no. 4, p. 709, 1990.
31. R. Anderson, S. Wang, C. Osiowy, and A. C. Issekutz, Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes, Journal of Virology, vol. 71, no. 6, pp. 4226-4232, 1997.
32. P. Avirutnan, P.Malasit, B. Seliger, S. Bhakdi, and M. Husmann, Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis, Journal of Immunology, vol. 161, no. 11, pp. 6338-6346, 1998.
33. C.-F. Lin, S.-C. Chiu, Y.-L. Hsiao et al., Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1, The Journal of Immunology, vol. 174, no. 1, pp. 395-403, 2005.
34. L.M. Espina, N. J. Valero, J.M.Hernández, and J. A.Mosquera, Increased apoptosis and expression of tumor necrosis factor caused by infection of cultured human monocytes with dengue virus, The American Journal of Tropical Medicine and Hygiene, vol. 68, no. 1, pp. 48-53, 2003.
35. J. P. Buyon,N. Shadick, R. Berkman et al., Surface expression of gp165/95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosus, Clinical Immunology and Immunopathology, vol. 46, no. 1, pp. 141-149, 1988.
36. D. S. Kyriakou, M. G. Alexandrakis, E. S. Kyriakou et al., Activated peripheral blood and endothelial cells in thalassemia patients, Annals of Hematology, vol. 80, no. 10, pp. 577-583, 2001.
37. J. D. Belcher, P. H. Marker, J. P. Weber, R. P. Hebbel, and G. M. Vercellotti, Activated monocytes in sickle cell disease: Potential role in the activation of vascular endothelium and vaso-occlusion, Blood, vol. 96, no. 7, pp. 2451-2459, 2000.
38. A.-F. Petit-Bertron, C. Fitting, J.-M. Cavaillon, and M. Adib- Conquy, Adherence influences monocyte responsiveness to interleukin-10, Journal of Leukocyte Biology, vol. 73, no. 1, pp. 145-154, 2003.
39. J. Paysant, M. Vasse, J. Soria et al., Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL-4, IL-10 and IL-13: consequences on cell adhesion to vitronectin and fibrinogen, British Journal of Haematology, vol. 100, no. 1, pp. 45-51, 1998.
40. T. M. Carlos and J.M.Harlan, Leukocyte-endothelial adhesion molecules, Blood, vol. 84, no. 7, pp. 2068-2101, 1994.
41. T. Jung, U. Schauer, C. Heusser, C. Neumann, and C. Rieger, Detection of intracellular cytokines by flowcytometry, Journal of Immunological Methods, vol. 159, no. 1-2, pp. 197-207, 1993.
42. C. Suharti, E. C. M. van Gorp, W. M. V. Dolmans et al., Cytokine patterns during dengue shock syndrome, European Cytokine Network, vol. 14, no. 3, pp. 172-177, 2003.
43. R. deWaalMalefyt, J.Haanen,H. Spits et al., Interleukin 10 (IL- 10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression, Journal of Experimental Medicine, vol. 174, no. 4, pp. 915-924, 1991.
44. M. A. Cassatella, L. Meda, S. Bonora, M. Ceska, and G. Constantin, Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 in mediating the production of IL-8 triggered by lipopolysaccharide, Journal of Experimental Medicine, vol. 178, no. 6, pp. 2207-2211, 1993.
45. K. W. Moore, A. OGarra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann, Interleukin-10, Annual Review of Immunology, vol. 11, pp. 165-190, 1993.
46. G. N. Malavige, L.-C. Huang, M. Salimi, L. Gomes, S. D. Jayaratne, and G. S. Ogg, Cellular and cytokine correlates of severe dengue infection, PLoS ONE, vol. 7, no. 11, Article ID e50387, 2012.